Aripiprazole (Abilify): reminder on known risk of gambling disorder

The MHRA has reminded healthcare professionals prescribing aripiprazole to be alert to the known risk of patients developing addictive gambling, following a rise in the number of reports received in 2023

Follow this news feed: